269 related articles for article (PubMed ID: 27747870)
1. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
[TBL] [Abstract][Full Text] [Related]
2. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.
Karunakaran S; Umapathy NS; Thangaraju M; Hatanaka T; Itagaki S; Munn DH; Prasad PD; Ganapathy V
Biochem J; 2008 Sep; 414(3):343-55. PubMed ID: 18522536
[TBL] [Abstract][Full Text] [Related]
4. Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells.
Cai A; Zheng H; Chen Z; Lin X; Li C; Yao Q; Bhutia YD; Ganapathy V; Chen R; Kou L
Biochem J; 2020 May; 477(10):1923-1937. PubMed ID: 32379301
[TBL] [Abstract][Full Text] [Related]
5. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer.
Schniers BK; Wachtel MS; Sharma M; Korac K; Rajasekaran D; Yang S; Sniegowski T; Ganapathy V; Bhutia YD
Biochem J; 2022 Mar; 479(5):719-730. PubMed ID: 35212370
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer.
Lu Y; Jiang Z; Wang K; Yu S; Hao C; Ma Z; Fu X; Qin MQ; Xu Z; Fan L
BMC Cancer; 2022 Jul; 22(1):833. PubMed ID: 35907820
[TBL] [Abstract][Full Text] [Related]
9. SLC6A14 Depletion Contributes to Amino Acid Starvation to Suppress EMT-Induced Metastasis in Gastric Cancer by Perturbing the PI3K/AKT/mTORC1 Pathway.
Guo Q; Xu W; Li X; Sun JL; Gu XC; Jing FB
Biomed Res Int; 2022; 2022():7850658. PubMed ID: 35865664
[TBL] [Abstract][Full Text] [Related]
10. PEPT1 is essential for the growth of pancreatic cancer cells: a viable drug target.
Schniers BK; Rajasekaran D; Korac K; Sniegowski T; Ganapathy V; Bhutia YD
Biochem J; 2021 Oct; 478(20):3757-3774. PubMed ID: 34569600
[TBL] [Abstract][Full Text] [Related]
11. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma.
Penheiter AR; Erdogan S; Murphy SJ; Hart SN; Felipe Lima J; Rakhshan Rohakhtar F; O'Brien DR; Bamlet WR; Wuertz RE; Smyrk TC; Couch FJ; Vasmatzis G; Bender CE; Carlson SK
Biomed Res Int; 2015; 2015():593572. PubMed ID: 26106611
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14.
McCracken AN; Edinger AL
Biochem J; 2015 Sep; 470(3):e17-9. PubMed ID: 26341486
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
[TBL] [Abstract][Full Text] [Related]
15. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
16. SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure.
Palazzolo L; Paravicini C; Laurenzi T; Adobati S; Saporiti S; Guerrini U; Gianazza E; Indiveri C; Anderson CMH; Thwaites DT; Eberini I
SLAS Discov; 2019 Oct; 24(9):928-938. PubMed ID: 31373846
[TBL] [Abstract][Full Text] [Related]
17. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
18. Regulation of SLC6A14 trafficking in breast cancer cells by heat shock protein HSP90β.
Połosak K; Papierniak-Wyglądała A; Nałęcz KA
Biochem Biophys Res Commun; 2022 Jul; 614():41-46. PubMed ID: 35569376
[TBL] [Abstract][Full Text] [Related]
19. Trafficking to the Cell Surface of Amino Acid Transporter SLC6A14 Upregulated in Cancer Is Controlled by Phosphorylation of SEC24C Protein by AKT Kinase.
Kovalchuk V; Nałęcz KA
Cells; 2021 Jul; 10(7):. PubMed ID: 34359969
[TBL] [Abstract][Full Text] [Related]
20. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
